Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Intraovarian platelet-rich plasma for poor ovarian response in assisted reproduction
IRCT20200905048630N5Phase 3Completed
- Sponsor
- Hormozgan University of Medical Sciences
- Start
- Oct 2023
- Countries
- 1
01
Overview
Phase 3, randomised, open-label trial of platelet-rich plasma in Diminished Ovarian Reserve (DOR), poor ovarian response (POR) and female infertility (2 arms), sponsored by Hormozgan University of Medical Sciences. Primary endpoints: Number of retrieved oocytes, Number of metaphase II oocytes retrieved and 5 more. Started Oct 2023; status: completed.
02
Drugs
platelet-rich plasma
03
Conditions
Diminished Ovarian Reserve (DOR)poor ovarian response (POR)female infertility
Beyond the preview
Go deeper on IRCT20200905048630N5.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20200905048630N5.